Arginyl-Glutamine

Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].

Product Specifications

CAS Number

[2483-17-2]

Product Name Alternative

H-Arg-Gln-OH

UNSPSC

12352209

Target

VEGFR

Type

Peptides

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/arginyl-glutamine.html

Solubility

10 mM in DMSO

Smiles

N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O

Molecular Formula

C11H22N6O4

Molecular Weight

302.33

References & Citations

[1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.